Harmar Mobility, LLC. in Raymore underwent a Food and Drug Administration (FDA) inspection on Feb. 6, according to data published on the FDA’s website.
The agency’s inspection reviewed the following aspects:
- Compliance: Devices
- Postmarket Assurance: Devices
The concluding report found that Harmar Mobility, LLC. did not require any corrective action in managing its operations.
The FDA regularly inspects facilities across the United States to verify compliance with FDA laws and regulations designed to promote public health. Inspection outcomes are made available to the public.
According to the agency’s website, the FDA is the federal agency tasked primarily with overseeing the production and distribution of human and animal drugs, biological items, medical equipment and tobacco products to ensure safety and quality.
Information in this article was sourced from the U.S. Food and Drug Administration. The original data can be reviewed here.
